Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: Why, when and for whom are they in line with the guidelines?
Event:
ESC Congress 2019
Topic:
Treatment
Session:
Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale?